Testing effectiveness (Phase 2)Active Not RecruitingNCT02105766
What this trial is testing
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
Who this might be right for
Sickle Cell DiseaseThalassemiaStem Cell Transplantation+1 more
National Heart, Lung, and Blood Institute (NHLBI) 56